Coronary artery dilation and left ventricular hypertrophy do not predict morbidity in children with sickle cell disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|62|1|115-119

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.1, 2015-01, pp. : 115-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Assessment of the Coronary Artery Disease and Systolic Dysfunction in Hypertensive Patients with the Dobutamine-Atropine Stress Echocardiography: Effect of the Left Ventricular Hypertrophy

By  

Cardiology, Vol. 89, Iss. 1, 1997-12 ,pp. : 52-58

Karger

Access to resources Recommend Favorite

Coronary Artery Ectasia in Atherosclerotic Coronary Artery Disease, Inflammatory Disorders, and Sickle Cell Disease

By  

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol. 33, Iss. 2, 2015-04 ,pp. : 79-88

John Wiley & Sons Inc

Access to resources Recommend Favorite

Apical Left Ventricular Hypertrophy and Mid‐Ventricular Obstruction in Fabry Disease

By  

ECHOCARDIOGRAPHY (ELECTRONIC), Vol. 32, Iss. 5, 2015-05 ,pp. : 860-863

John Wiley & Sons Inc

Access to resources Recommend Favorite

Catheter Ablation of Ventricular Tachycardia as the First‐Line Therapy in Patients With Coronary Artery Disease and Preserved Left Ventricular Systolic Function: Long‐Term Results

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 26, Iss. 10, 2015-10 ,pp. : 1105-1110

John Wiley & Sons Inc

Access to resources Recommend Favorite

Outcomes of Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention and Medical Therapy for Multivessel Disease with and without Left Ventricular Dysfunction

By  

Cardiology, Vol. 101, Iss. 1-3, 2004-02 ,pp. : 21-28

Karger

Access to resources Recommend Favorite